Vigora is approved for a maximum of one 100 mg dose within any 24-hour period. Taking more than this amount increases the risk of serious side effects without providing additional benefit.
Sildenafil can cause a modest reduction in blood pressure, especially when combined with nitrates or certain antihypertensive drugs. Most healthy men experience negligible changes, but individuals with cardiovascular disease should have their blood pressure monitored.
Moderate alcohol consumption does not typically interfere with the efficacy of Vigora, but excessive drinking can worsen dizziness or hypotension. It is advisable to limit intake to avoid potential side effects.
A erection lasting longer than four hours (priapism) is a medical emergency. Seek immediate care at an emergency department; timely treatment reduces the risk of permanent penile damage.
Concurrent use can cause additive blood-pressure-lowering effects. If your prescriber recommends it, start with the lowest possible dose of Vigora and monitor for dizziness or faintness.
Sildenafil is not approved for treating sexual dysfunction in women, and its safety and efficacy have not been established in this population.
The medication should be taken approximately 30 minutes to 1 hour before anticipated sexual activity. Taking it earlier may delay onset, while taking it later may reduce effectiveness.
Yes, an empty stomach can lead to a quicker onset because food, especially high-fat meals, can delay absorption. However, the overall effectiveness remains comparable.
Sildenafil is available as a generic prescription medicine in the UK. Generic formulations contain the same active ingredient and are subject to the same regulatory standards as Vigora.
Vigora is a brand-name medication that contains the active ingredient sildenafil. It is formulated as a 100 mg oral pill and belongs to the therapeutic class of erectile dysfunction (ED) treatments. In the United Kingdom, Vigora is classified as a prescription-only medicine (POM) and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The medication works by enhancing blood flow to the penis, helping men achieve and maintain an erection sufficient for sexual activity.
Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor. By blocking the PDE5 enzyme, it prevents the breakdown of cyclic guanosine monophosphate (cGMP) within the smooth muscle cells of the penile arteries. Elevated cGMP levels lead to relaxation of these smooth muscles, allowing the blood vessels to dilate and increase blood flow to the corpus cavernosum during sexual stimulation. The drug’s onset of action typically begins within 30-60 minutes, with peak effects occurring around 1 hour after ingestion. Its duration of effect can last up to 4-6 hours, depending on individual metabolism and dosage.
Vigora is indicated for the treatment of erectile dysfunction in adult men. Erectile dysfunction is defined as the persistent inability to achieve or sustain an erection adequate for satisfactory sexual performance. The medication is intended for use only when sexual stimulation is present; it does not cause an erection without this stimulus.
Sildenafil, the active component of Vigora, has a well-documented approved indication for pulmonary arterial hypertension (PAH) under the brand name Revatio. While this is not an off-label use of Vigora, it demonstrates the broader therapeutic potential of the molecule.
Some clinical investigations have explored the use of sildenafil for:
These applications are not approved by the MHRA for the Vigora brand. Any off-label use must be guided by a qualified healthcare professional, with careful risk-benefit assessment.
If any of these conditions apply, discussion with a healthcare professional is essential before initiating therapy.
Patients should disclose all prescription medicines, over-the-counter products, supplements, and herbal remedies to their prescriber to avoid unforeseen interactions.
Signs of overdose may include severe hypotension, prolonged erection, or intense headache. Immediate medical attention is recommended. No specific antidote exists; treatment is supportive, with attention to blood pressure and symptom relief.
Vigora does not require tapering. If therapy is to be stopped, the medication can be discontinued abruptly without withdrawal symptoms.
Routine laboratory monitoring is not required for most patients using sildenafil for erectile dysfunction. However, healthcare providers may:
If side effects become severe or persistent, patients should contact their prescriber promptly.
This article provides educational information about Vigora and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
